Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2928

Actual shortage: 212 (7%)
Anticipated shortage: 0 (0%)
Avoided shortage: 10 (0%)
Resolved: 2706 (92%)

Discontinuation Reports

299

To be discontinued: 2 (1%)
Discontinued: 297 (99%)
Reversed: 0 (0%)

Late reports

361 (11%)

Overdue reports

85 (40%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
OCTREOTIDE FOR INJECTABLE SUSPENSION 30MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Resolved 2022-08-18 2024-06-13 166975
OCTREOTIDE FOR INJECTABLE SUSPENSION 10MG POWDER FOR SUSPENSION, EXTENDED-RELEASE KIT Resolved 2022-03-04 2022-03-24 156070
OCTREOTIDE FOR INJECTABLE SUSPENSION 30MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Resolved 2024-10-11 2024-11-08 240046
OCTREOTIDE FOR INJECTABLE SUSPENSION 10MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Resolved 2024-10-17 2025-01-30 240525
OCTREOTIDE FOR INJECTABLE SUSPENSION 30MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Actual shortage 2024-11-28 2025-04-28 244081
OCTREOTIDE FOR INJECTABLE SUSPENSION 20MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Actual shortage 2025-01-09 2025-03-27 247309
ONDANSETRON INJECTION 2MG SOLUTION Actual shortage 2017-03-13 2017-10-05 1746
ONDANSETRON INJECTION 2MG SOLUTION Actual shortage 2017-03-13 2017-10-05 1754
OXALIPLATIN INJECTION 5MG SOLUTION Resolved 2020-10-15 2020-11-26 126533
OXALIPLATIN INJECTION 5MG SOLUTION Resolved 2019-09-12 2019-11-22 93650
OXALIPLATIN INJECTION 5MG SOLUTION Resolved 2019-09-26 2019-11-14 94840
OXALIPLATIN INJECTION 5MG SOLUTION Resolved 2019-06-18 2019-08-06 86905
OXALIPLATIN INJECTION 5MG SOLUTION Resolved 2019-06-18 2019-07-16 86908
OXALIPLATIN INJECTION 5MG SOLUTION Resolved 2019-06-27 2019-08-21 87684
OXALIPLATIN INJECTION 5MG SOLUTION Resolved 2020-02-21 2020-05-08 106955
OXALIPLATIN INJECTION 5MG SOLUTION Resolved 2021-01-22 2021-03-18 132270
OXALIPLATIN INJECTION 5MG SOLUTION Resolved 2021-06-03 2021-08-05 140393
PEDIATRIX 160MG SOLUTION Resolved 2023-06-19 2023-06-27 195643
PEDIATRIX 160MG SOLUTION Resolved 2023-06-16 2023-06-27 195106
PEDIATRIX 160MG SOLUTION Resolved 2022-08-18 2023-06-27 167194

Showing 501 to 520 of 2928

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION 40MG POWDER FOR SOLUTION Discontinued 2021-09-23 2021-09-23 146061
NOVAMOXIN 125MG TABLET (CHEWABLE) Discontinued 2019-04-11 2019-04-11 81321
NOVAMOXIN 500MG CAPSULE Discontinued 2017-06-27 2017-06-27 14046
NOVAMOXIN 250MG GRANULES FOR SUSPENSION Discontinued 2019-04-11 2019-04-11 81316
NOVAMOXIN 250MG CAPSULE Discontinued 2020-01-24 2020-01-24 104289
NOVAMOXIN 25MG GRANULES FOR SUSPENSION Discontinued 2019-04-11 2019-04-11 81393
NOVAMOXIN 125MG TABLET (CHEWABLE) Discontinued 2019-10-25 2019-10-26 97251
NOVASEN 325MG TABLET (DELAYED-RELEASE) Discontinued 2018-10-12 2018-10-12 63955
NOVASEN 325MG TABLET (DELAYED-RELEASE) Discontinued 2018-10-12 2018-10-12 63959
NOVASEN 650MG TABLET (DELAYED-RELEASE) Discontinued 2018-10-12 2018-10-12 63964
NOVO-PROFEN 400MG TABLET Discontinued 2018-10-19 2018-10-19 64920
NOVO-PROFEN 200MG TABLET Discontinued 2019-04-11 2019-04-11 81310
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION 0.5G 4G POWDER FOR SOLUTION Discontinued 2023-11-15 2023-11-15 210194
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION 0.375G 3G POWDER FOR SOLUTION Discontinued 2023-11-15 2023-11-15 210191
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64589
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64592
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64615
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64623
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64626
RATIO-ATORVASTATIN Discontinued 2018-10-19 2018-10-19 64852

Showing 81 to 100 of 299